BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Foster Delivery Science Receives Grant From University of Connecticut to Develop Processes for Oral Dose Drug Delivery


3/25/2013 12:00:48 PM

PUTNAM, CT USA – (March 25, 2013) – Foster Delivery Science, a leading pharmaceutical contract research and manufacturing provider in the field of hot melt extrusion, has been awarded a Manufacturer’s Technical Assistance Program (MTAP) grant from the University of Connecticut for development of novel processes to improve manufacturability and absorption of poorly water soluble drugs in the body. MTAP is part of an investment by the state of Connecticut in the University Technology Park aimed at supporting manufacturing innovation in the state.

Many newly discovered pharmaceutical ingredients are poorly water soluble and result in low absorption rates in the body. Foster’s hot melt extrusion technology enhances bioavailability through melt dispersion of active pharmaceutical ingredients in a polymer matrix. The resulting drug/polymer matrix is then ground into powder form and pressed into tablets.

Foster and University of Connecticut will collaborate to develop continuous injection molding of the tablets from the drug/polymer matrix form, eliminating the powder grinding process. In addition Foster and University of Connecticut intend to explore foaming technology to reduce density and increase porosity of the molded tablets in an effort to further enhance the body’s absorption of drugs.

“Roughly half of the new drugs discovered are poorly soluble and require special processing, such as hot melt extrusion, for drug delivery dose forms,” said Tony Listro, Managing Director at Foster Delivery Science. “By combining our expertise in hot melt extrusion and the polymer processing resources at University of Connecticut we believe we can make meaningful advancements in manufacturing and performance of formulations involving poorly water soluble drugs.”

For more information, please visit www.deliveryscience.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES